AI-POWERED GENOMIC INSIGHTS
Revolutionizing Enhancer Discovery & Design with CREsted
This deep analysis of the Nature Methods article "CREsted: modeling genomic and synthetic cell-type-specific enhancers across tissues and species" reveals how advanced deep learning is transforming our understanding of the genomic regulatory code.
Executive Impact
CREsted offers unparalleled capabilities for dissecting cell-type identity drivers, predicting enhancer activity with high accuracy, and designing synthetic regulatory elements across diverse biological systems. This translates into accelerated research and development in genomics.
0.82
Enhancer Model Accuracy (Pearson r)
171
Cell-type Specific Enhancers Validated
4
Species/Tissues Covered
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
CREsted provides detailed insights into enhancer codes of mouse cortical cell types, demonstrating high prediction accuracy and cross-species generalization.
0.82
Pearson Correlation (Mouse Cortex)
Achieved on log-transformed predictions and peak heights for mouse motor cortex test set regions, demonstrating strong predictive capabilities.
| Feature | CREsted (Fine-tuned) | gReLU (22M) |
|---|---|---|
| All Test-Set Peaks (Pearson r) | 0.82*** | 0.79 |
| Cell-Type-Specific Peaks (Pearson r) | 0.79*** | 0.76 |
| TFBS Identification | Highly Accurate | Lower Accuracy |
CREsted consistently outperforms gReLU models on both all test-set peaks and cell-type-specific peaks.
Cross-Species Prediction Example
CREsted successfully scored the chicken UACA gene locus using the mouse Pvalb class model, resulting in a strong correlation (r = 0.62). This indicates the potential for identifying and decoding candidate enhancers in species without scATAC-seq data.
CREsted successfully models human PBMC data, accurately identifies validated TFBSs, and interprets complex enhanceosome structures.
0.71
Pearson Correlation (Human PBMC)
Achieved on cell-type-specific test peaks for human peripheral blood mononuclear cells, confirming robust performance across tissues.
Enhancer Code Interpretation Process
Nucleotide Contribution Scores
→
Motif Identification (tfmodisco-lite)
→
Motif Clustering
→
TF Matching (scRNA-seq)
IFNB1 Enhanceosome Deciphered
DeepPBMC retrieved a large part of the interferon-β (IFNB1) enhanceosome's complexity, only missing a few TFBSs (p50, c-Jun, and one IRF). Compared to Borzoi, DeepPBMC identified substantially more (34%) important nucleotides.
CREsted compares mesenchymal-like cancer cell states across tumor types and cell lines, and demonstrates efficient transfer learning from foundation models.
| Characteristic | Melanoma MES-like | GBM MES-like |
|---|---|---|
| Shared Regulators | AP-1, TEAD, RUNX, NFI, ATF/CREB | AP-1, TEAD, RUNX, NFI, ATF/CREB |
| Cell-line Specific | TEAD motifs | SOX, RFX motifs |
| Biopsy Correlation (Topic 8) | Strong | Strong |
CREsted reveals shared and specific regulatory programs across different MES-like cancer cell states.
0.79
Enhancer Activity Recall (in vivo)
DeepBICCN2 classified 171 in vivo-validated cell-type-specific enhancers with an average recall of 0.79 in a multi-label classification setting, highlighting biological relevance.
CREsted facilitates the design and in vivo validation of cell-type-specific and dual-specificity synthetic enhancers in a developing zebrafish atlas.
Synthetic Enhancer Design Workflow
Define Target Cell Type
→
Optimize DNA Sequence (ISE)
→
In Vivo Validation (Reporter Assays)
→
Decipher Enhancer Code
Dual-Specificity Enhancers
CREsted enabled the generation of dual-specificity enhancers for cardiac vs. somatic muscle cells. While sequences converged to targets, precisely controlling expression magnitude remains nontrivial.
74
% Validated Zebrafish Enhancers Specific
74% of 54 validated enhancers showed high and specific predictions for their corresponding cell-type class, demonstrating the model's accuracy for organism-level design.
Calculate Your Potential ROI
Deep learning models are revolutionizing genomic research, but their deployment requires significant computational resources and expertise. Our AI solutions streamline the process, leading to substantial savings and faster discovery.
Annual Savings Potential
$0
Hours Reclaimed Annually
0
Your AI Implementation Roadmap
Deploying advanced AI for genomic analysis requires a structured approach. Our roadmap ensures a smooth transition and maximizes the value derived from CREsted.
Phase 1: Data Preprocessing & Model Training
Leverage CREsted’s optimized workflows for scATAC-seq data preprocessing, including topic modeling or pseudobulk aggregation, and robust model training (from scratch or via transfer learning).
Phase 2: Enhancer Code Interpretation
Utilize gradient-based methods and in silico mutagenesis to identify critical nucleotides and TFBSs, linking them to TF candidates via scRNA-seq data for deep biological insights.
Phase 3: Synthetic Enhancer Design & Validation
Employ in silico evolution or TFBS implantation to design novel enhancers with cell-type specificity, followed by in vivo validation to confirm functional outputs across tissues and species.
Ready to Transform Your Genomic Research?
Unlock the full potential of your scATAC-seq data with CREsted. Our experts are ready to guide you through implementation and maximize your discovery pipeline.
Ready to Get Started?
Book Your Free Consultation.
Let's Discuss Your AI Strategy!
Lets Discuss Your Needs
Select a Date
Sun
Mon
Tue
Wed
Thu
Fri
Sat